W. L. Gore & Associates Expands Endovascular Treatment Portfolio with Conformal Medical Acquisition W. L. Gore & Associates has announced its acquisition of Conformal Medical, enhancing its offerings in endovascular treatments and stroke prevention technologies.

W. L. Gore & Associates Expands Endovascular Treatment Portfolio with Conformal Medical Acquisition #USA #Newark #Conformal_Medical #CLAAS_AcuFORM #W._L._Gore

W. L. Gore & Associates Acquires Conformal Medical, Strengthening Its Endovascular Treatment Portfolio W. L. Gore & Associates has officially acquired Conformal Medical, enhancing its capabilities in innovative endovascular treatments like the CLAAS® AcuFORM™ system.

W. L. Gore & Associates Acquires Conformal Medical, Strengthening Its Endovascular Treatment Portfolio #United_States #Newark #Conformal_Medical #CLAAS_AcuFORM #W._L._Gore

W. L. Gore & Associates Enhances Endovascular Treatments with Acquisition of Conformal Medical W. L. Gore & Associates has announced the acquisition of Conformal Medical, enhancing its capabilities in endovascular treatment solutions with innovative technology.

W. L. Gore & Associates Enhances Endovascular Treatments with Acquisition of Conformal Medical #United_States #Newark #Conformal_Medical #CLAAS_AcuFORM #W._L._Gore

W. L. Gore & Associates Expands Endovascular Solutions with Conformal Medical Acquisition W. L. Gore & Associates has announced its acquisition of Conformal Medical to enhance its endovascular treatment capabilities with innovative technology.

W. L. Gore & Associates Expands Endovascular Solutions with Conformal Medical Acquisition #USA #Newark #Conformal_Medical #CLAAS_AcuFORM #W.L.Gore

W. L. Gore & Associates to Acquire Conformal Medical: A Major Step in Endovascular Treatments W. L. Gore & Associates has announced its acquisition of Conformal Medical, enhancing its capabilities in endovascular treatments, particularly for stroke prevention.

W. L. Gore & Associates to Acquire Conformal Medical: A Major Step in Endovascular Treatments #USA #Newark #Conformal_Medical #CLAAS_AcuFORM #Gore_Associates

Conformal Medical Initiates CONFORM Pivotal Trial Enrollment for Innovative LAAO Device in Europe Conformal Medical has launched the CONFORM Pivotal Trial in Europe to assess the CLAAS AcuFORM LAAO device, marking a significant advancement in stroke prevention for AFib patients.

Conformal Medical Initiates CONFORM Pivotal Trial Enrollment for Innovative LAAO Device in Europe #None #Paris #Conformal_Medical #CLAAS_AcuFORM #LAAO_Device

Conformal Medical Initiates First Patient Enrollment in E.U. for Revolutionary LAAO Study Conformal Medical has launched patient enrollment in Europe for its groundbreaking study using the CLAAS AcuFORM device, aimed at reducing stroke risk in AFib patients.

Conformal Medical Initiates First Patient Enrollment in E.U. for Revolutionary LAAO Study #None #Conformal_Medical #CLAAS_AcuFORM #LAAO_Device

Conformal Medical Secures $32 Million Series D Extension for Innovative LAAO Technology Advancements Conformal Medical has closed a $32 million Series D funding round to further develop its innovative left atrial appendage occlusion technology aimed at reducing stroke risk.

Conformal Medical Secures $32 Million Series D Extension for Innovative LAAO Technology Advancements #United_States #Nashua,_NH #Conformal_Medical #CLAAS_AcuFORM #LAAO_Technology

Conformal Medical Presents Promising Results of GLACE Study at Annual AF Symposium The GLACE Study, featuring Conformal Medical's new CLAAS AcuFORM device, showcases early results at the Annual AF Symposium in Boston, highlighting its innovative design.

Conformal Medical Presents Promising Results of GLACE Study at Annual AF Symposium #United_States #Boston #AF_Symposium #Conformal_Medical #CLAAS_AcuFORM